Retreatment of chemotherapy-resistant metastatic choriocarcinoma with immunotherapy

INTRODUCTION: Recurrent metastatic choriocarcinoma is a rare disease with historically limited guidance in the literature regarding standardized treatment protocols. In this case report, we review the course of a patient with recurrent metastatic choriocarcinoma re-treated with single agent pembroli...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Adriana J., Finch, Lindsey, Pearson, Joseph Matt, Pinto, Andre, Huang, Marilyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920859/
https://www.ncbi.nlm.nih.gov/pubmed/35300054
http://dx.doi.org/10.1016/j.gore.2022.100955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920859/
https://www.ncbi.nlm.nih.gov/pubmed/35300054
http://dx.doi.org/10.1016/j.gore.2022.100955

Ejemplares similares